Gastrointestinal Drugs Market Research Report | Forecast up to 2024
As per the research report, the global gastrointestinal drugs market is anticipated to be worth US$61.1 bn by 2024. By drug class, acid neutralizers segment not led in the past, but is also expected to remain in the leading position in the coming years. This is because, acid neutralizers are cost effective and also because the increasing prevalence of gastroesophageal reflux disease (GERD), will drive this segment.
Asia Pacific to Emerge Most Lucrative in Gastrointestinal Drugs Market
On the basis of geography, the global gastrointestinal drugs market is expected to be led by North America. Favorable reimbursement policies, and increasing geriatric population, who are more prone to gastrointestinal disorders, will drive the region’s growth during the forecast period from 2016 to 2024. North America held 41% of the market in 2016. Europe has also been witnessing healthy growth and is anticipated to continue being an attractive region for gastrointestinal drugs market. “The emergence of biosimilars for treating inflammatory bowel diseases will also be a key growth driver for the market in Europe,” says a TMR analyst. However, Asia Pacific is estimated to be the region with maximum opportunities for growth in the coming years. The growing investments and funding in the field of life science research and advanced therapies for the treatment of gastrointestinal diseases in developing nations such as China and India will fuel the growth of the Asia Pacific market.
Request to download and view full ToC -
Rising Awareness about Availability of Treatment Options Driving Demand for Gastrointestinal Drugs
A report published by World Gastroenterology Organization states that around 15 to 25% of the people across the globe are suffering from gastro-esophageal reflux disease (GERD). This is positively impacting the demand for gastrointestinal drugs. The growing awareness about the disease and the increasing availability of treatment options is boosting the growth of the market. The growing investments in research and development activities for innovation of new drugs will further the growth of the market.
Request to view Sample Report -
Unavailability of Permanent Cure to Pose a Challenge for Market Players
The etiology of irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) remains a mystery and this is expected to hamper the growth of the global gastrointestinal drugs market. The lack of permanent cure for gastrointestinal diseases will also act as a challenge for market players. On the positive side, the consistent technological advancements in the treatment therapies of gastrointestinal diseases are projected to reduce the impact of the aforementioned restraints, states a TMR analyst.
Gastrointestinal Drugs Market Report is available @ US$ 5795
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gastrointestinal Drugs Market Research Report | Forecast up to 2024 here
News-ID: 709364 • Views: 446
More Releases from Transparency Market Research
Wearable EEG Devices Market: Growing incidences of Neurovascular Disorders is Dr …
According to new market research titled 'Wearable EEG Devices Market to 2027 - Global Analysis and Forecasts by Channel and Application.' The global wearable EEG devices market is expected to reach US$ 1,556.35 Mn in 2027 from US$ 745.05 Mn in 2018. The market is projected to grow with a CAGR of 8.7% from 2019-2027. The report provides trends prevailing in the global wearable EEG devices market and the factors
Decentralized Electricity Generation Market - Global Industry Analysis, Share, G …
Global Decentralized Electricity Generation Market: Overview With the increasing installation of smart grids and the rising number of electricity generation resources, the power generation industry has been undergoing a significant change over the recent past. The modification in the grid structure, which permits decentralization of electricity generation, is acting as the main driving force behind the substantial growth of the global market for decentralized electricity generation. The main objective of this research
Global Sucralose Market Outlook In The Developed And Emerging Industry
Sucralose Market Overview Sugar substitute market is witnessing an increasing demand driven by the increasing sales of various sugar substitutes such as natural sweeteners and artificial sweeteners. Sucralose, an artificial sweetener used as a sugar substitute is highly preferred by consumers owing to its zero calorie attribute. Though sucralose is 600 times sweeter than sugar but interestingly it is not identified as the carbohydrate by the human body. Sucralose has its
Flavored Syrup Market - Growth Powered with Latest Development Scenario & Influe …
Flavored Syrup Market Introduction Global syrup market is witnessing a significant demand generated by the food and beverage industry. Consumers' increasing preference for different and personalized flavors in food has driven the syrup manufacturers to produce a wide range of flavored syrups. Flavored syrups contain artificial or natural flavorings mixed along with sugar and water. Obtain Report Details @ https://www.transparencymarketresearch.com/flavored-syrup-market.html Increasing demand of flavored syrups especially among the consumers contributes to the
More Releases for Gastrointestinal
Gastrointestinal Devices Market – Latest Advancements
Gastrointestinal Devices Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Gastrointestinal Devices market research report is a professional and in-depth study on the current state of Gastrointestinal Devices Industry. The Gastrointestinal Devices Market research report covers the present scenario and the growth prospects
Gastrointestinal Devices Market Report 2018: Segmentation by Type (Gastrointesti …
Global Gastrointestinal Devices market research report provides company profile for Coloplast, Given Imaging, CONMED, Covidien, Ethicon, Olympus, Boston Scientific and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation
Gastrointestinal Drugs Market - Upcoming Trends
The global gastrointestinal drugs market is consolidated with the top three players accounting for a whopping 61% of the market collectively in 2016. These three players are: Valeant Pharmaceuticals Inc., Janssen Biotech Inc., and Takeda Pharmaceutical. While the market is moderately competitive at present, future holds much competitiveness among players and thus, the degree of competition is expected to be increase in the forecast period, states a report by Transparency
Global Gastrointestinal Drugs Sales Market Report 2017
In this report, the global Gastrointestinal Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. The Values marked with XX is confidential data. To know more about CAGR figures fill in your information so that our business development executive can get in touch with you. Request Sample Copy
Recent Advances in Gastrointestinal Stents Industry Development
Global Gastrointestinal Stents Market: Snapshot The global gastrointestinal stents market displays competition despite strong foothold of a few dominant players. To outdo the competition, mergers and acquisitions to enhance technical expertise is what players are vying for in this market. Development of differentiator products is also what players are looking upon to stay ahead in the game. Among the key factors catalyzing growth of the global gastrointestinal stents market are
Global Gastrointestinal Industry Report 2016
Global Gastrointestinal Industry 2016 Market Overview, Size, Share, Trends, Analysis, Technology, Applications, Growth, Market Status, Demands, Insights, Development, Research and Forecast 2016-2020. The analysts of the global Gastrointestinal market report have taken on the challenge of procuring insightful data from reliable resources and precisely segregating critical market dynamics, given the voluminous amount of information available. Established and novice players in the Gastrointestinal market can secure their position on the cutting edge